Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Titan Pharmaceuticals, Inc

+1 (650) 244-4990
Website

Advertisement

Advertisement

Photos

400 Oyster Point Blvd Ste 505
South San Francisco, CA 94080
+1 (650) 244-4990
https://www.titanpharm.com
Titan Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system disorders, cardiovascular disease, bone disease and other disorders. Titan's products in development utilize technologies that have the potential to significantly improve the treatment of these diseases. Titan also establishes partnerships with government institutions and other leading pharmaceutical development companies. Titan Pharmaceuticals is headquartered in San Francisco.

Also at this address

Panalpina

11th & Kissling Street Apartments

Nanotemper Technologies Inc

Kovarus Inc

Find related places

Storage

Storage

Warehouses

Warehouses

Own this business?
Claim it
See a problem?

You might also like

Avg Technologies
Business services, nec, nec, Custom computer programming services, Art gallery

Avg Technologies

Dynavax Technologies Corporation was founded in August 1996. The company discovers, develops and intends to commercialize products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases, using proprietary approaches that alter immune system responses in specific ways. Its clinical development programs are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Dynavax s pipeline includes: TOLAMBA, a ragweed allergy immunotherapeutic, which has completed a large-scale Phase 2/3 clinical trial, and is in a supportive clinical trial in ragweed allergic children; HEPLISAV, a hepatitis B vaccine that is in a pivotal Phase 3 clinical trial; a cancer therapy in a Phase 2 clinical trial; and an asthma immunotherapeutic that has shown preliminary safety and pharmacologic activity in a Phase 2a clinical trial.
Portola Pharmaceuticals
Business services, nec, nec, Services, nec, nec, Drugs and drug proprietaries

Portola Pharmaceuticals

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company. Its bioresearch and drug development efforts are focused toward global markets and the treatment of cardiovascular disease and inflammation.
AMAG Pharmaceuticals
Drugs and drug proprietaries, Drugs affecting neoplasms and endrocrine systems

AMAG Pharmaceuticals

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. The company has collaborated with pharmaceutical partners to develop and market product candidates. Rigel has product development programs in inflammatory/autoimmune diseases, such as rheumatoid arthritis, thrombocytopenia, asthma and allergy, as well as in cancer. Its lead product candidate, R788, completed Phase I clinical trials for the treatment of rheumatoid arthritis, in 2005.
United States›California›South San Francisco›Titan Pharmaceuticals, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell